1. Home
  2. CRAI vs COLL Comparison

CRAI vs COLL Comparison

Compare CRAI & COLL Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • CRAI
  • COLL
  • Stock Information
  • Founded
  • CRAI 1965
  • COLL 2002
  • Country
  • CRAI United States
  • COLL United States
  • Employees
  • CRAI N/A
  • COLL N/A
  • Industry
  • CRAI Other Consumer Services
  • COLL Biotechnology: Pharmaceutical Preparations
  • Sector
  • CRAI Consumer Discretionary
  • COLL Health Care
  • Exchange
  • CRAI Nasdaq
  • COLL Nasdaq
  • Market Cap
  • CRAI 1.2B
  • COLL 1.1B
  • IPO Year
  • CRAI 1998
  • COLL 2015
  • Fundamental
  • Price
  • CRAI $184.55
  • COLL $29.70
  • Analyst Decision
  • CRAI Buy
  • COLL Strong Buy
  • Analyst Count
  • CRAI 1
  • COLL 6
  • Target Price
  • CRAI $212.00
  • COLL $42.00
  • AVG Volume (30 Days)
  • CRAI 40.1K
  • COLL 508.5K
  • Earning Date
  • CRAI 10-31-2024
  • COLL 02-20-2025
  • Dividend Yield
  • CRAI 1.06%
  • COLL N/A
  • EPS Growth
  • CRAI 24.54
  • COLL 757.11
  • EPS
  • CRAI 6.18
  • COLL 2.16
  • Revenue
  • CRAI $672,592,000.00
  • COLL $599,245,000.00
  • Revenue This Year
  • CRAI $10.80
  • COLL $13.20
  • Revenue Next Year
  • CRAI $3.40
  • COLL $17.63
  • P/E Ratio
  • CRAI $29.84
  • COLL $13.73
  • Revenue Growth
  • CRAI 10.74
  • COLL 9.62
  • 52 Week Low
  • CRAI $97.31
  • COLL $28.97
  • 52 Week High
  • CRAI $210.70
  • COLL $42.29
  • Technical
  • Relative Strength Index (RSI)
  • CRAI 43.88
  • COLL 40.90
  • Support Level
  • CRAI $181.99
  • COLL $29.48
  • Resistance Level
  • CRAI $210.70
  • COLL $31.14
  • Average True Range (ATR)
  • CRAI 7.29
  • COLL 1.10
  • MACD
  • CRAI -0.41
  • COLL 0.14
  • Stochastic Oscillator
  • CRAI 8.92
  • COLL 9.91

About CRAI CRA International Inc.

CRA International Inc is a U.S.-based advisory firm that provides economic, financial, and management consultancy services. The company advises clients on economic and financial issues relating to litigation and regulatory proceedings and helps businesses set important business strategies and solve performance-related issues. The company's clients include domestic and foreign companies, government agencies, public and private utilities, and national and international trade associations. CRA International generates majority of its revenue from the United States.

About COLL Collegium Pharmaceutical Inc.

Collegium Pharmaceutical Inc is a specialty pharmaceutical company. The company is engaged in developing and planning to commercialize abuse-deterrent products that incorporate its patented DETERx platform technology for the treatment of chronic pain and other diseases. The DETERx platform technology is designed to maintain the extended-release and safety profiles of highly abused drugs in the face of various methods including chewing, crushing, and dissolving. Its product portfolio includes Xtampza ER, which is an abuse-deterrent, extended-release, oral formulation of oxycodone; and Nucynta Products, which are extended-release and immediate-release formulations of tapentadol; Belbuca, and Symproic.

Share on Social Networks: